topotecan has been researched along with Sarcoma 180 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, G; Ci, T; Ding, J; Yu, L | 1 |
Abe, H; Fujita, H; Ishii, R; Okamoto, M; Takao, A; Takeda, K | 1 |
Abe, H; Arase, H; Fujita, H; Ishii, R; Okamoto, M; Takao, A | 1 |
3 other study(ies) available for topotecan and Sarcoma 180
Article | Year |
---|---|
Enhancement of the fraction of the active form of an antitumor drug topotecan via an injectable hydrogel.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Carriers; Hydrogen-Ion Concentration; Injections, Subcutaneous; Mice; Mice, Inbred Strains; Molecular Structure; Polyethylene Glycols; Polyglactin 910; Sarcoma 180; Solubility; Surface Properties; Temperature; Topotecan; Xenograft Model Antitumor Assays | 2011 |
[Pharmacokinetics of SK & F 104864 in experimental animals. I. Plasma level].
Topics: Animals; Antineoplastic Agents; Camptothecin; Female; Half-Life; Infusions, Intravenous; Male; Mice; Mice, Inbred ICR; Rabbits; Sarcoma 180; Topotecan | 1995 |
[Pharmacokinetics of SK & F 104864 in experimental animals. II. Tissue distribution].
Topics: Animals; Antineoplastic Agents; Camptothecin; Female; Injections, Intravenous; Mice; Mice, Inbred ICR; Sarcoma 180; Tissue Distribution; Topotecan | 1995 |